KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenon Pharmaceuticals (XENE) Shares Issued (2016 - 2025)

Xenon Pharmaceuticals (XENE) has disclosed Shares Issued for 13 consecutive years, with $1.4 million as the latest value for Q4 2025.

  • Quarterly Shares Issued rose 2848.94% to $1.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.0 million through Dec 2025, up 10457.45% year-over-year, with the annual reading at $5.0 million for FY2025, 10457.45% up from the prior year.
  • Shares Issued for Q4 2025 was $1.4 million at Xenon Pharmaceuticals, down from $2.4 million in the prior quarter.
  • The five-year high for Shares Issued was $29.5 million in Q3 2023, with the low at -$29.5 million in Q4 2023.
  • Average Shares Issued over 5 years is $1.0 million, with a median of $106000.0 recorded in 2021.
  • The sharpest move saw Shares Issued surged 7330.19% in 2022, then plummeted 491316.67% in 2023.
  • Over 5 years, Shares Issued stood at $15000.0 in 2021, then crashed by 60.0% to $6000.0 in 2022, then tumbled by 491316.67% to -$29.5 million in 2023, then surged by 100.16% to $47000.0 in 2024, then surged by 2848.94% to $1.4 million in 2025.
  • According to Business Quant data, Shares Issued over the past three periods came in at $1.4 million, $2.4 million, and $65000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.